(LMT) Lockheed Martin - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5398301094
Stock: Combat Aircraft, Missiles, Satellites, Helicopters, Radar, Warships
Total Rating 67
Risk 88
Buy Signal 0.57
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.94% |
| Yield on Cost 5y | 4.53% |
| Yield CAGR 5y | 5.94% |
| Payout Consistency | 98.4% |
| Payout Ratio | 45.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.0% |
| Relative Tail Risk | -17.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.33 |
| Alpha | 35.80 |
| Character TTM | |
|---|---|
| Beta | 0.243 |
| Beta Downside | 0.153 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.79% |
| CAGR/Max DD | 0.38 |
Description: LMT Lockheed Martin January 27, 2026
Lockheed Martin (NYSE:LMT) is a global aerospace and defense integrator that designs, builds, and sustains advanced technology systems across four business segments: Aeronautics (combat, air-mobility and unmanned aircraft), Missiles & Fire Control (air- and missile-defense, precision-strike weapons, logistics and energy-management), Rotary & Mission Systems (helicopters, naval platforms, radar/laser, cyber and training solutions) and Space (satellites, launch services, strategic and classified space-security systems). The company’s customer base is dominated by the U.S. government, with additional revenue from allied foreign militaries and commercial partners.
Key recent metrics (FY 2025, per the latest 10-K) show revenue of $67 billion, net income of $7.2 billion, and a record order backlog of $165 billion-approximately 2.5 times FY 2025 revenue. R&D spending remains high at $2.3 billion (≈3.4 % of revenue) to sustain technology leadership. The sector is buoyed by a 3.5 % YoY increase in the U.S. defense budget (FY 2025 ≈ $842 billion) and a 6 % CAGR in the global space-launch market, both of which underpin demand for Lockheed Martin’s high-margin programs such as F-35, THAAD and the Orion spacecraft.
For a deeper quantitative view, consult the ValueRay dashboard.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 5.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 2.04 > 1.0 |
| NWC/Revenue: 2.70% < 20% (prev 3.42%; Δ -0.72% < -1%) |
| CFO/TA 0.14 > 3% & CFO 8.56b > Net Income 5.02b |
| Net Debt (17.58b) to EBITDA (8.73b): 2.01 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (231.9m) vs 12m ago -2.15% < -2% |
| Gross Margin: 10.16% > 18% (prev 0.10%; Δ 1006 % > 0.5%) |
| Asset Turnover: 130.0% > 50% (prev 127.7%; Δ 2.28% > 0%) |
| Interest Coverage Ratio: 6.30 > 6 (EBITDA TTM 8.73b / Interest Expense TTM 1.12b) |
Altman Z'' 1.94
| A: 0.03 (Total Current Assets 25.36b - Total Current Liabilities 23.34b) / Total Assets 59.84b |
| B: 0.23 (Retained Earnings 14.03b / Total Assets 59.84b) |
| C: 0.12 (EBIT TTM 7.04b / Avg Total Assets 57.73b) |
| D: 0.13 (Book Value of Equity 6.72b / Total Liabilities 53.12b) |
| Altman-Z'' Score: 1.94 = BBB |
Beneish M -3.73
| DSRI: 0.24 (Receivables 3.90b/15.31b, Revenue 75.06b/71.04b) |
| GMI: 0.97 (GM 10.16% / 9.88%) |
| AQI: 0.95 (AQ_t 0.43 / AQ_t-1 0.45) |
| SGI: 1.06 (Revenue 75.06b / 71.04b) |
| TATA: -0.06 (NI 5.02b - CFO 8.56b) / TA 59.84b) |
| Beneish M-Score: -3.73 (Cap -4..+1) = AAA |
What is the price of LMT shares?
As of February 07, 2026, the stock is trading at USD 623.58 with a total of 1,095,346 shares traded.
Over the past week, the price has changed by -1.68%, over one month by +19.45%, over three months by +33.99% and over the past year by +43.14%.
Over the past week, the price has changed by -1.68%, over one month by +19.45%, over three months by +33.99% and over the past year by +43.14%.
Is LMT a buy, sell or hold?
Lockheed Martin has received a consensus analysts rating of 3.71.
Therefor, it is recommend to hold LMT.
- StrongBuy: 7
- Buy: 4
- Hold: 12
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the LMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 591.5 | -5.1% |
| Analysts Target Price | 591.5 | -5.1% |
| ValueRay Target Price | 703.5 | 12.8% |
LMT Fundamental Data Overview February 01, 2026
P/E Trailing = 29.5261
P/E Forward = 21.0526
P/S = 1.9555
P/B = 21.2104
P/EG = 2.0646
Revenue TTM = 75.06b USD
EBIT TTM = 7.04b USD
EBITDA TTM = 8.73b USD
Long Term Debt = 20.53b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 21.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.58b USD (from netDebt column, last quarter)
Enterprise Value = 164.34b USD (146.76b + Debt 21.70b - CCE 4.12b)
Interest Coverage Ratio = 6.30 (Ebit TTM 7.04b / Interest Expense TTM 1.12b)
EV/FCF = 23.79x (Enterprise Value 164.34b / FCF TTM 6.91b)
FCF Yield = 4.20% (FCF TTM 6.91b / Enterprise Value 164.34b)
FCF Margin = 9.20% (FCF TTM 6.91b / Revenue TTM 75.06b)
Net Margin = 6.68% (Net Income TTM 5.02b / Revenue TTM 75.06b)
Gross Margin = 10.16% ((Revenue TTM 75.06b - Cost of Revenue TTM 67.43b) / Revenue TTM)
Gross Margin QoQ = 11.47% (prev 12.04%)
Tobins Q-Ratio = 2.75 (Enterprise Value 164.34b / Total Assets 59.84b)
Interest Expense / Debt = 1.34% (Interest Expense 290.0m / Debt 21.70b)
Taxrate = 12.21% (187.0m / 1.53b)
NOPAT = 6.18b (EBIT 7.04b * (1 - 12.21%))
Current Ratio = 1.09 (Total Current Assets 25.36b / Total Current Liabilities 23.34b)
Debt / Equity = 3.23 (Debt 21.70b / totalStockholderEquity, last quarter 6.72b)
Debt / EBITDA = 2.01 (Net Debt 17.58b / EBITDA 8.73b)
Debt / FCF = 2.54 (Net Debt 17.58b / FCF TTM 6.91b)
Total Stockholder Equity = 6.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.69% (Net Income 5.02b / Total Assets 59.84b)
RoE = 80.53% (Net Income TTM 5.02b / Total Stockholder Equity 6.23b)
RoCE = 26.31% (EBIT 7.04b / Capital Employed (Equity 6.23b + L.T.Debt 20.53b))
RoIC = 22.32% (NOPAT 6.18b / Invested Capital 27.69b)
WACC = 6.08% (E(146.76b)/V(168.46b) * Re(6.81%) + D(21.70b)/V(168.46b) * Rd(1.34%) * (1-Tc(0.12)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.93%
[DCF Debug] Terminal Value 84.08% ; FCFF base≈6.26b ; Y1≈5.49b ; Y5≈4.46b
Fair Price DCF = 480.9 (EV 127.70b - Net Debt 17.58b = Equity 110.12b / Shares 229.0m; r=6.08% [WACC]; 5y FCF grow -15.11% → 2.90% )
EPS Correlation: -30.41 | EPS CAGR: -2.75% | SUE: 0.02 | # QB: 0
Revenue Correlation: 74.01 | Revenue CAGR: 8.52% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=7.04 | Chg30d=-0.043 | Revisions Net=+1 | Analysts=10
EPS current Year (2026-12-31): EPS=29.41 | Chg30d=+0.030 | Revisions Net=+3 | Growth EPS=+36.9% | Growth Revenue=+4.5%
EPS next Year (2027-12-31): EPS=31.20 | Chg30d=-0.049 | Revisions Net=-1 | Growth EPS=+6.1% | Growth Revenue=+4.2%
P/E Forward = 21.0526
P/S = 1.9555
P/B = 21.2104
P/EG = 2.0646
Revenue TTM = 75.06b USD
EBIT TTM = 7.04b USD
EBITDA TTM = 8.73b USD
Long Term Debt = 20.53b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 21.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.58b USD (from netDebt column, last quarter)
Enterprise Value = 164.34b USD (146.76b + Debt 21.70b - CCE 4.12b)
Interest Coverage Ratio = 6.30 (Ebit TTM 7.04b / Interest Expense TTM 1.12b)
EV/FCF = 23.79x (Enterprise Value 164.34b / FCF TTM 6.91b)
FCF Yield = 4.20% (FCF TTM 6.91b / Enterprise Value 164.34b)
FCF Margin = 9.20% (FCF TTM 6.91b / Revenue TTM 75.06b)
Net Margin = 6.68% (Net Income TTM 5.02b / Revenue TTM 75.06b)
Gross Margin = 10.16% ((Revenue TTM 75.06b - Cost of Revenue TTM 67.43b) / Revenue TTM)
Gross Margin QoQ = 11.47% (prev 12.04%)
Tobins Q-Ratio = 2.75 (Enterprise Value 164.34b / Total Assets 59.84b)
Interest Expense / Debt = 1.34% (Interest Expense 290.0m / Debt 21.70b)
Taxrate = 12.21% (187.0m / 1.53b)
NOPAT = 6.18b (EBIT 7.04b * (1 - 12.21%))
Current Ratio = 1.09 (Total Current Assets 25.36b / Total Current Liabilities 23.34b)
Debt / Equity = 3.23 (Debt 21.70b / totalStockholderEquity, last quarter 6.72b)
Debt / EBITDA = 2.01 (Net Debt 17.58b / EBITDA 8.73b)
Debt / FCF = 2.54 (Net Debt 17.58b / FCF TTM 6.91b)
Total Stockholder Equity = 6.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.69% (Net Income 5.02b / Total Assets 59.84b)
RoE = 80.53% (Net Income TTM 5.02b / Total Stockholder Equity 6.23b)
RoCE = 26.31% (EBIT 7.04b / Capital Employed (Equity 6.23b + L.T.Debt 20.53b))
RoIC = 22.32% (NOPAT 6.18b / Invested Capital 27.69b)
WACC = 6.08% (E(146.76b)/V(168.46b) * Re(6.81%) + D(21.70b)/V(168.46b) * Rd(1.34%) * (1-Tc(0.12)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.93%
[DCF Debug] Terminal Value 84.08% ; FCFF base≈6.26b ; Y1≈5.49b ; Y5≈4.46b
Fair Price DCF = 480.9 (EV 127.70b - Net Debt 17.58b = Equity 110.12b / Shares 229.0m; r=6.08% [WACC]; 5y FCF grow -15.11% → 2.90% )
EPS Correlation: -30.41 | EPS CAGR: -2.75% | SUE: 0.02 | # QB: 0
Revenue Correlation: 74.01 | Revenue CAGR: 8.52% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=7.04 | Chg30d=-0.043 | Revisions Net=+1 | Analysts=10
EPS current Year (2026-12-31): EPS=29.41 | Chg30d=+0.030 | Revisions Net=+3 | Growth EPS=+36.9% | Growth Revenue=+4.5%
EPS next Year (2027-12-31): EPS=31.20 | Chg30d=-0.049 | Revisions Net=-1 | Growth EPS=+6.1% | Growth Revenue=+4.2%